Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats via the Nrf2 Pathway

Y. Li, T. Wang, P. Sun, W. Zhu, Y. Chen, M. Chen, X. Yang, X. Du, Y. Zhao

. 2023 ; 72 (4) : 511-520. [pub] 2023Aug31

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23018217

Farrerol (FA) is a traditional Chinese herbal medicine known for its anti-inflammatory and anti-oxidative properties in various diseases. Ferroptosis is an iron-dependent oxidative stress-induced cell death. It is characterized by lipid peroxidation and glutathione depletion and is involved in neuronal injury. However, the role of FA in inhibiting ferroptosis in hypoxic-ischemic encephalopathy (HIE) and its underlying mechanisms are not yet completely elucidated. This study aimed to investigate whether FA could mediate ferroptosis and explore its function and molecular mechanism in HIE. A neonatal rat model of HIE was used, and rats were treated with FA, ML385 (a specific inhibitor of nuclear factor erythroid 2-related factor 2 [Nrf2]), or a combination of both. Neurological deficits, infarction volume, brain water content, pathological changes, and iron ion accumulation in the brain tissues were measured using the Zea-Longa scoring system and triphenyl tetrazolium chloride (TTC), hematoxylin-eosin (HE), and Perls' staining. The expression levels of GSH-Px, MDA, SOD, and ROS in brain tissues were also evaluated. Western blot analysis was performed to analyze the expression of the Nrf2 pathway and ferroptosis-related proteins. The results showed that FA administration significantly reduced neuronal damage, infarct volume, cerebral edema, and iron ion accumulation and inhibited MDA and ROS levels while promoting GSH-Px and SOD levels. FA also increased the expression levels of glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), Nrf2, and HO-1. Moreover, the combination of ML385 and FA in HIE abolished the FA protective effects. Therefore, the study concludes that FA exerts a neuroprotective effect after HIE by inhibiting oxidative stress and ferroptosis via the Nrf2 signaling pathway.

000      
00000naa a2200000 a 4500
001      
bmc23018217
003      
CZ-PrNML
005      
20231116090659.0
007      
ta
008      
231107s2023 xr da f 000 0|eng||
009      
AR
024    7_
$2 doi $a 10.33549/physiolres.935040
035    __
$a (PubMed)37795893
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Li, Yongfu $u Department of Science and education, Pu’er People’s Hospital, Yunnan, People’s Republic of China
245    10
$a Farrerol Alleviates Hypoxic-Ischemic Encephalopathy by Inhibiting Ferroptosis in Neonatal Rats via the Nrf2 Pathway / $c Y. Li, T. Wang, P. Sun, W. Zhu, Y. Chen, M. Chen, X. Yang, X. Du, Y. Zhao
520    9_
$a Farrerol (FA) is a traditional Chinese herbal medicine known for its anti-inflammatory and anti-oxidative properties in various diseases. Ferroptosis is an iron-dependent oxidative stress-induced cell death. It is characterized by lipid peroxidation and glutathione depletion and is involved in neuronal injury. However, the role of FA in inhibiting ferroptosis in hypoxic-ischemic encephalopathy (HIE) and its underlying mechanisms are not yet completely elucidated. This study aimed to investigate whether FA could mediate ferroptosis and explore its function and molecular mechanism in HIE. A neonatal rat model of HIE was used, and rats were treated with FA, ML385 (a specific inhibitor of nuclear factor erythroid 2-related factor 2 [Nrf2]), or a combination of both. Neurological deficits, infarction volume, brain water content, pathological changes, and iron ion accumulation in the brain tissues were measured using the Zea-Longa scoring system and triphenyl tetrazolium chloride (TTC), hematoxylin-eosin (HE), and Perls' staining. The expression levels of GSH-Px, MDA, SOD, and ROS in brain tissues were also evaluated. Western blot analysis was performed to analyze the expression of the Nrf2 pathway and ferroptosis-related proteins. The results showed that FA administration significantly reduced neuronal damage, infarct volume, cerebral edema, and iron ion accumulation and inhibited MDA and ROS levels while promoting GSH-Px and SOD levels. FA also increased the expression levels of glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), Nrf2, and HO-1. Moreover, the combination of ML385 and FA in HIE abolished the FA protective effects. Therefore, the study concludes that FA exerts a neuroprotective effect after HIE by inhibiting oxidative stress and ferroptosis via the Nrf2 signaling pathway.
650    _2
$a zvířata $7 D000818
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a mozková hypoxie a ischemie $x farmakoterapie $7 D020925
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a faktor 2 související s NF-E2 $7 D051267
650    12
$a ferroptóza $7 D000079403
650    _2
$a reaktivní formy kyslíku $7 D017382
650    _2
$a glutathion $7 D005978
650    _2
$a železo $7 D007501
650    _2
$a superoxiddismutasa $7 D013482
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wang, Ting $u Department of Reproductive Medicine, Pu’er People’s Hospital, Yunnan, People’s Republic of China
700    1_
$a Sun, Ping $u Department of Science and education, Pu’er People’s Hospital, Yunnan, People’s Republic of China
700    1_
$a Zhu, Wei $u Department of Science and education, The People's Hospital of Xishuangbanna Dai Autonomous Prefecture, Yunnan, People’s Republic of China
700    1_
$a Chen, Yirong $u Department of nosocomial infection administration, Pu’er People’s Hospital, Yunnan, People’s Republic of China
700    1_
$a Chen, Mo $u Department of Gastrointestinal and Burn Plastic Surgery, Pu’er People’s Hospital, Yunnan, People’s Republic of China,
700    1_
$a Yang, Xu $u Department of Science and education, Pu’er People’s Hospital, Yunnan, People’s Republic of China
700    1_
$a Du, Xiaodong $u Department of Reproductive Medicine, Pu’er People’s Hospital, Yunnan, People’s Republic of China
700    1_
$a Zhao, Yuan $u Department of Oncology, Pu’er People’s Hospital, Yunnan, People’s Republic of China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 4 (2023), s. 511-520
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37795893 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20231107 $b ABA008
991    __
$a 20231116090654 $b ABA008
999    __
$a ok $b bmc $g 2009495 $s 1204620
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 72 $c 4 $d 511-520 $e 2023Aug31 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20231107

Najít záznam

Citační ukazatele

Možnosti archivace